Tonix Pharmaceuticals Holding Corp. (TNXP) [Rocket]

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15
	10-K	10-K	10-K	10-K	10-K	10-K/A	10-K	10-K
Revenues	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Cost of goods sold	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Gross profit	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Gross margin
Selling, general and administrative [+]	30.2	23.5	14.4	10.6	8.8	7.9	10.4	12.7
General and administrative	30.2	23.5	14.4	10.6	8.8	7.9	10.4	12.7
Research and development	81.9	68.8	36.2	18.2	17.6	13.3	28.5	35.5
EBITDA [+]	-110.8	-92.3	-50.5	-28.8	-26.3	-21.2	-38.8	-48.0
EBITDA growth	20.1%	82.8%	75.3%	9.6%	23.8%	-45.3%	-19.2%	73.8%
EBITDA margin
Depreciation and amortization	1.3	0.1	0.0	0.0	0.1	0.1	0.2	0.2
EBIT [+]	-112.1	-92.3	-50.5	-28.8	-26.3	-21.3	-39.0	-48.2
EBIT growth	21.4%	82.8%	75.2%	9.5%	23.6%	-45.4%	-19.1%	74.1%
EBIT margin
Interest income	1.9	0.0	0.0	0.2	0.2	0.2	0.1	0.1
Interest income	1.9	0.0	0.0	0.2	0.2	0.2	0.1	0.1
Pre-tax income	-110.2	-92.3	-50.5	-28.6	-26.1	-21.1	-38.8	-48.1
Income taxes	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Tax rate	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Net income	-116.9	-92.3	-52.2	-31.1	-29.4	-21.1	-38.8	-48.1
Net margin

Basic EPS [+]	($3.27)	($8.10)	($0.55)	($19.33)	($259.85)	($31.69)	($15.41)	($28.62)
Growth	-59.6%	1369.3%	-97.1%	-92.6%	719.9%	105.7%	-46.2%	934.8%
Diluted EPS [+]	($3.27)	($8.10)	($0.55)	($19.33)	($259.85)	($31.69)	($15.41)	($28.62)
Growth	-59.6%	1369.3%	-97.1%	-92.6%	719.9%	105.7%	-46.2%	934.8%

Shares outstanding (basic) [+]	35.7	11.4	94.6	1.6	0.1	0.7	2.5	1.7
Growth	213.8%	-88.0%	5780.5%	1323.9%	-83.1%	-73.6%	50.1%	-83.2%
Shares outstanding (diluted) [+]	35.7	11.4	94.6	1.6	0.1	0.7	2.5	1.7
Growth	213.8%	-88.0%	5780.5%	1323.9%	-83.1%	-73.6%	50.1%	-83.2%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.